0001209191-21-014560.txt : 20210225
0001209191-21-014560.hdr.sgml : 20210225
20210225214816
ACCESSION NUMBER: 0001209191-21-014560
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210223
FILED AS OF DATE: 20210225
DATE AS OF CHANGE: 20210225
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kihara James
CENTRAL INDEX KEY: 0001816160
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50768
FILM NUMBER: 21683498
MAIL ADDRESS:
STREET 1: C/O ACADIA PHARMACEUTICALS INC.
STREET 2: 12830 EL CAMINO REAL, SUITE 400
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001070494
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 061376651
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3611 VALLEY CENTRE DRIVE
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-558-2871
MAIL ADDRESS:
STREET 1: 3611 VALLEY CENTRE DRIVE
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-23
0
0001070494
ACADIA PHARMACEUTICALS INC
ACAD
0001816160
Kihara James
C/O ACADIA PHARMACEUTICALS, INC.
12830 EL CAMINO REAL, SUITE 400
SAN DIEGO
CA
92130
0
1
0
0
Principal Accounting Officer
Stock Options (Right to Buy)
49.74
2021-02-23
4
A
0
6187
0.00
A
2031-02-23
Common Stock
6187
6187
D
Restricted Stock Units
2021-02-23
4
A
0
3360
0.00
A
Common Stock
3360
3360
D
25% of the shares subject to the Stock Option will vest and become exercisable on February 23, 2022. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter.
Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock.
The restricted stock units vest in four equal annual installments beginning February 23 2022.
/s/ Austin D. Kim, Attorney-in-Fact
2021-02-25